Structure-activity relationships of 17α-derivatives of estradiol as inhibitors of steroid sulfatase

Journal of Medicinal Chemistry

Volumn 43, Issue 23, 2000, Pages 4465-4478

  Boivin, R P ^a   Luu The, V ^a   Lachance, R ^a   Labrie, F ^a   Poirier, D ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTRADIOL; ESTROGEN; MICROSOME ENZYME; PRASTERONE SULFATE; STEROID; STERYL SULFATASE;

ARTICLE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; HYDROPHOBICITY; STRUCTURE ACTIVITY RELATION;

ARYLSULFATASES; CELL LINE; ENZYME INHIBITORS; ESTRADIOL; HUMANS; STERYL-SULFATASE; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EID: 0034676325     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0001166     Document Type: Article

References (71)

1. History of LHRH agonist and combination therapy in prostate cancer
2. Endocrine treatment of breast cancer in women
3. Basic guide to the mechanisms of antiestrogen action
4. Enzymatic regulation of estradiol-17β concentrations in human breast cancer cells
5. The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology
6. Gonadal steroid sulfates and sulfatase. V. Human testicular steroid sulfatase: Partial characterization and possible regulation by free steroids
7. Steroid sulfatase activity in human lung tissue and in endothelial pulmonary cells in culture
8. Steroid sulfatase activity in human fetal membranes
9. Sulfohydrolase activity for estrone sulfate and dehydroepiandrosterone sulfate in human fetal menbranes and decidua around the time of parturition
10. Estrone and dehydroepiandrosterone sulfatase activities in normal and pathological human endometrium biopsies
11. Regional and subcellular distribution of aryl- and steroid sulfatases in brain
12. 4 isomerase (3β-HSD), 17β-HSD, 5α-reductase and aromatase activities in the rhesus monkey
13. Human placental sterylsulfatase. Interaction of the isolated enzyme with substrate, products, transition-state analogues, amino acid modifiers and anion transport inhibitors
14. The sulfatase gene family
15. Cloning and expression of human steroid sulfatase
16. Cloning and expression of steroid sulfatase cDNA and the frequent occurrence of deletions in STS deficiency: Inplications for X-Y interchange
17. Intracrinology: Its impact on prostate cancer
18. Intracrinology
19. Interaction of 5-androstene-3β,17β-diol with estradiol and dihydrotestosterone receptors in human myometrical and mammary tissue
20. 5-steroids in the ZR-75-1 human breast cancer cell line
21. Androstenedione and androst-5-ene-3β,17β-diol stimulate DMBA-induced mammary tumours: Role of aromatase
22. Concentrations of estrone, estradiol and their sulfates, and evaluation of sulfatase and aromatase activities in patients with breast fibroadenoma
23. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients
24. Importance of estrogen sulfates in breast cancer
25. Enzymatic control of oestrogen production in human breast cancer: Relative significance of aromatase versus sulphatase pathways
26. Serum and urinary estrone sulfate during the menstrual cycle, measured by a direct radioimmunoassay, and fate of exogenously injected estrone sulfate
27. The measurement of estrone sulfate in plasma
28. DHEA and peripheral androgen and estrogen formation: Intracrinology
29. Action of danazol on the conversion of estrone sulfate to estradiol and on the sulfatase activity in the MCF-7, T-47D and MDA-MB-231 human mammary cancer cells
30. Steroid sulfatase inhibitors
31. The development of steroid sulphatase inhibitors
32. Oestrone 3-O-(N-acetyl) sulphamate, a potential molecular probe of the active site of oestrone sulphatase
33. Heteroatom-substituted analogues of the active-site directed inhibitor estra-1,3,5(10)-trien-17 one-3-sulphamate inhibit estrone sulphatase by a different mechanism
34. Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulphamate
35. Estrone sulfamate: Potent inhibitor of estrone sulfatase with therapeutic potential
36. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase
37. In vivo activity of 4-coumarin-7-O-sulfamate, a nonsteroidal, nonestrogenic steroid sulfatase inhibitor
38. Active site directed inhibition of estrone sulfatase by nonsteroidal coumarin sulfamates
39. Development of (p-O-sulfamoyl)-N-alkanoyl-phenylalkylamines as nonsteroidal estrone sulfatase inhibitors
40. Structure-activity relationship studies of the amide functionality in (p-O-sulfamoyl)-N-alkanoyl tyramines as estrone sulfatase inhibitors
41. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines
42. Memory enhancement mediated by the steroid sulphatase inhibitor (p-O-sulfamoyl)-N-tetradecanoyl tyramine
43. Synthesis and sulfatase inhibitory activities of nonsteroidal estrone sulfatase inhibitors
44. Synthesis of estrogen sulfamates: Compounds with a novel endocrinological profile
45. Development of potent nonestrogenic estrone sulfatase inhibitors
46. The development of A-ring modified analogues of oestrone-3-O-sulphamate as potent steroid sulfatase inhibitors with reduced oestrogenicity
47. Potent inhibition of steroid sulfatase activity by 3-O-sulfamate 17α-benzyl(or 4′-tert-butylbenzyl)estra-1,3,5(10)-trienes: Combination of two substituents at positions C3 and C17α of estradiol
48. D-ring alkylamide derivatives of estradiol: Effect on ER-binding affinity and antiestrogenic activity
49. Synthesis and biological activity of 17α-alkynylamide derivatives of estradiol
50. Overview of a rational approach to design type I 17β-hydroxysteroid dehydrogenase inhibitors without estrogenic activity: Chemical synthesis and biological evaluation
51. C16 and C17 derivatives of estradiol as inhibitors of 17β-hydroxysteroid dehydrogenase type 1: Chemical synthesis and structure-activity relationships
52. Synthesis and evaluation of estradiol derivatives with 16α-(bromoalkylamide), 16α-(bromoalkyl) or 16α-(bromoalkynyl) side chain as inhibitors of 17β-hydroxysteroid dehydrogenase type 1 without estrogenic activity
53. Synthesis of 16-(bromoalkyl)-estradiols having inhibitory effect on human placental estradiol 17β-hydroxysteroid dehydrogenase (17β-HSD type 1)
54. 16α-propyl derivatives of estradiol as inhibitors of 17β-hydroxysteroid dehydrogenase Type 1
55. N-butyl, N-methyl-11-(3′,17′β-dihydroxy-1′,3′,5′(10 )-estratrien-16′α-yl-)-9(R/S)-bromo-undecanamide: Synthesis and 17β-HSD inhibiting, estrogenic and antiestrogenic activities
56. 17α-alkyl- or 17α-substituted benzyl-17β-estradiols: A new family of potent estrone-sulfatase inhibitors
57. 17α-allyl estradiol analogues as candidates for development of high-affinity fluorescein-estradiol conjugates
58. 17α-Substituted analogues of estradiol for the development of fluorescent estrogen receptor ligants
59. The estradiol pharmacophore: Ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site
60. Highly efficient nucleophilic addition of alkyl Grignard reagents to 17-ketosteroids in the presence of cerium (III) chloride: Synthesis of 17α-propyl-17β-hydroxy-4-androsten-3-one, an androgen receptor antagonist
61. Convenient general method for the preparation of primary alkyllithiums by lithium-iodine exchange
62. New biospecific adsorbents for the purification of estradiol receptor
63. A short stereoselective route to 16α-(substituted-alkyl) estradiol derivatives
64. 13C NMR data
65. Inhibition of steroid sulfatase activity by danazol
66. Peripheral androgen levels in danazol-treated premenopausal women
67. 17α-Alkan(or alkyn)amide derivatives of estradiol as inhibitors of steroid-sulfatase activity
68. Derivation of a possible transition-state for the reaction catalysed by the enzyme estrone sulfatase (ES)
69. 13C nuclear magnetic resonance study of 17α-substituted estradiols